Sort
141,003 grants matching “cytokine”
Combinatorial and computational design of bnAb mRNA vaccines for HIV
$785,418Daniel G Anderson · Massachusetts Institute Of Technology · R61 · FY2023 · AI
Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary Disease (COPD)
$785,354R Graham Barr · Columbia University Health Sciences · R01 · FY2011 · HL
Mechanisms of myocarditis and progressive cardiac fibrosis in chronic Trypanosoma cruzi infection.
$785,194Kathryn Marie Jones · Baylor College Of Medicine · R01 · FY2023 · AI
A trial to determine the effect of psoriasis treatment on cardiometabolic disease
$785,162Joel M Gelfand · University Of Pennsylvania · R01 · FY2012 · HL
Genomic and Circulating Predictors of PAH response
$785,069Anna R Hemnes · Vanderbilt University Medical Center · R01 · FY2025 · HL
Genomic and Circulating Predictors of PAH response
$785,069Anna R Hemnes · Vanderbilt University Medical Center · R01 · FY2024 · HL
Preclinical Assessment of a Multi-Head Electroporation Device for Delivery of Bio
$785,031Kathleen A Cashman · Geneva Foundation · R01 · FY2017 · AI
Impact of microbiota on AIDS-Kaposiâs sarcoma development and therapy
$785,019Shou-Jiang Gao · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Targeting natural killer cells to HIV in intravenous drug users
$785,000Catherine A Blish · Stanford University · DP1 · FY2019 · DA
Targeting natural killer cells to HIV in intravenous drug users
$785,000Catherine A Blish · Stanford University · DP1 · FY2022 · DA
Targeting natural killer cells to HIV in intravenous drug users
$785,000Catherine A Blish · Stanford University · DP1 · FY2020 · DA
Targeting natural killer cells to HIV in intravenous drug users
$785,000Catherine A Blish · Stanford University · DP1 · FY2018 · DA
Targeting natural killer cells to HIV in intravenous drug users
$785,000Catherine A Blish · Stanford University · DP1 · FY2021 · DA
Advanced TRPA1 Inhibitor for the Treatment of Chlorine Inhalation Injury
$784,984Sven-Eric Jordt · Duke University · U01 · FY2021 · ES
Design And Development Of Experimental Therapeutics
$784,982Nigel H. Greig · National Institute On Aging · ZIA · FY2010 · AG
Cohort and biomarkers for COVID-19 severity, natural history, and reinfection
$784,970Martin J Blaser · Rutgers Biomedical And Health Sciences · R01 · FY2023 · AI
Cohort and biomarkers for COVID-19 severity, natural history, and reinfection
$784,970Martin J Blaser · Rbhs-Robert Wood Johnson Medical School · R01 · FY2021 · AI
Cohort and biomarkers for COVID-19 severity, natural history, and reinfection
$784,970Martin J Blaser · Rutgers Biomedical And Health Sciences · R01 · FY2022 · AI
Regulation of immunity by the cGAS-STING pathway
$784,885Jonathan C Kagan · Boston Children'S Hospital · R01 · FY2022 · AI
Prenatal and Neonatal Biologic Markers for Autism
$784,863Lisa A Croen · Kaiser Foundation Research Institute · R01 · FY2014 · ES
Generation and Function of NK Cell Memory
$784,741Ulrich H Von Andrian · Harvard Medical School · R01 · FY2013 · AI
Establishment of a causal link between AD and L1 retrotransposons
$784,679Alysson R. Muotri · University Of California, San Diego · R01 · FY2023 · AG
Diesel, Allergens and Gene Interaction and Child Atopy
$784,548Grace Lemasters · University Of Cincinnati · R01 · FY2007 · ES
Enhancing potency of the MERS vaccine by a novel ASP-1+alum adjuvant combination
$784,531Sara Lustigman · New York Blood Center · U01 · FY2017 · AI
The Role of Vascular MR-Regulated Genes in Vascular Function and Disease
$784,522Iris Z Jaffe · Tufts Medical Center · R01 · FY2022 · HL